Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic review
Mingmei Li, Karen Caeyenberghs
Neuroscience & Biobehavioral Reviews (2018) Vol. 92, pp. 304-317
Closed Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 484
Chemotherapy: how to reduce its adverse effects while maintaining the potency?
Brianna Brianna, Sau Har Lee
Medical Oncology (2023) Vol. 40, Iss. 3
Closed Access | Times Cited: 81
Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 102
Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?
Sanne B. Schagen, Andrey S. Tsvetkov, Annette Compter, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 3, pp. 173-185
Closed Access | Times Cited: 65
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
Carlo G. Tocchetti, Pietro Ameri, Rudolf A. de Boer, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 11, pp. 1820-1834
Open Access | Times Cited: 69
Promising Antineoplastic Actions of Melatonin
Gaia Favero, Enrico Moretti, Francesca Bonomini, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 60
Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer
Gwen Schroyen, Jeroen Blommaert, Donatienne Van Weehaeghe, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4198-4198
Open Access | Times Cited: 42
Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Anxiety, depression, and concentration in cancer survivors: National Health and Nutrition Examination Survey results
Joanna E. Fardell, Chase Irwin, Janette Vardy, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 5
Open Access | Times Cited: 18
Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE
Harvey R. Fernandez, Ashima Varma, Sarah A. Flowers, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3842-3842
Open Access | Times Cited: 42
Identifying early diffusion imaging biomarkers of regional white matter injury as indicators of executive function decline following brain radiotherapy: A prospective clinical trial in primary brain tumor patients
Kathryn R. Tringale, Tanya T. Nguyen, Naeim Bahrami, et al.
Radiotherapy and Oncology (2018) Vol. 132, pp. 27-33
Open Access | Times Cited: 42
Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer
Bihong T. Chen, Taihao Jin, Sunita K. Patel, et al.
Breast Cancer Research and Treatment (2018) Vol. 172, Iss. 2, pp. 363-370
Open Access | Times Cited: 38
Systematic review of longitudinal studies on chemotherapy‐associated subjective cognitive impairment in cancer patients
Hee‐Ju Kim, Sun Ok Jung, Hyang Kim, et al.
Psycho-Oncology (2020) Vol. 29, Iss. 4, pp. 617-631
Closed Access | Times Cited: 38
Functional connectome biotypes of chemotherapy-related cognitive impairment
Shelli R. Kesler, Melissa Petersen, Vikram Rao, et al.
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 4, pp. 483-493
Open Access | Times Cited: 37
Systematic Review and Meta-Analysis of Clinically Relevant Executive Functions Tests Performance after COVID-19
Boris B. Velichkovsky, A.Y. Razvaliaeva, Alena A. Khlebnikova, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-9
Open Access | Times Cited: 12
Brain gray matter reduction and premature brain aging after breast cancer chemotherapy: a longitudinal multicenter data pooling analysis
Michiel B. de Ruiter, Rachael Deardorff, Jeroen Blommaert, et al.
Brain Imaging and Behavior (2023) Vol. 17, Iss. 5, pp. 507-518
Closed Access | Times Cited: 12
A systematic review of rehabilitation programs for cognitive impairment related to breast cancer: Different programs at different times?
Marianne Merceur, Karen T. Reilly, I. Bonan, et al.
Annals of Physical and Rehabilitation Medicine (2024) Vol. 67, Iss. 5, pp. 101832-101832
Open Access | Times Cited: 4
A Qualitative Longitudinal Study on the Adaptation and Coping Strategies of Men with Testicular Cancer
Bianka Karlíková, Branislav Uhrecký, Jitka Gurňáková
Human Affairs (2025)
Closed Access
Cancer-Related Cognitive Impairment: A Practical Guide for Oncologists
Yu Zhang, Shelli R. Kesler, Jörg Dietrich, et al.
JCO Oncology Practice (2025)
Closed Access
Cognitive Performance and Psychological Distress in Breast Cancer Patients at Disease Onset
Jochen Kaiser, Jörg Dietrich, M Amiri, et al.
Frontiers in Psychology (2019) Vol. 10
Open Access | Times Cited: 31
Chemobrain as a Product of Growing Success in Chemotherapy - Focus On Glia As Both A Victim And A Cure
Piotr Walczak, Mirosław Janowski
Neuropsychiatry (2019) Vol. 09, Iss. 01
Open Access | Times Cited: 30
Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy
Brenna C. McDonald, Kathleen Van Dyk, Rachael Deardorff, et al.
Breast Cancer Research and Treatment (2022) Vol. 194, Iss. 1, pp. 113-126
Open Access | Times Cited: 16
A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects
Zev M. Nakamura, Allison M. Deal, Eliza M. Park, et al.
Cancer Medicine (2023) Vol. 12, Iss. 7, pp. 8172-8183
Open Access | Times Cited: 10
Agomelatine attenuates cisplatin-induced cognitive impairment via modulation of BDNF/TrkB signaling in rat hippocampus
Sinan Saral, Atilla Topçu, Mehmet Alkanat, et al.
Journal of Chemical Neuroanatomy (2023) Vol. 130, pp. 102269-102269
Closed Access | Times Cited: 9
Cognitive alterations and brain functional changes following chemotherapy treatment in breast cancer patients: A systematic review on resting-state fMRI studies
L Conti, Silvia Francesca Maria Pizzoli, Chiara Marzorati, et al.
Applied Neuropsychology Adult (2024), pp. 1-16
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top